Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02ENI
|
||||
| Former ID |
DNC004656
|
||||
| Drug Name |
(Z)-1-(benzo[d]oxazol-2-yl)octadec-9-en-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529193] | ||
| Formula |
C25H37NO2
|
||||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)C1=NC2=CC=CC=C2O1
|
||||
| InChI |
1S/C25H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23(27)25-26-22-19-17-18-21-24(22)28-25/h9-10,17-19,21H,2-8,11-16,20H2,1H3/b10-9-
|
||||
| InChIKey |
APIPEDDJLOMNRC-KTKRTIGZSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529193] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.